APA

Amato D. A., Bruckner H., Guerry D., Ash A., Falkson G., Borden E. C., Creech R. H., Savlov E. D. & Cunningham T. J. (19871217). Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma. : Investigational new drugs.

Chicago

Amato D A, Bruckner H, Guerry D, Ash A, Falkson G, Borden E C, Creech R H, Savlov E D and Cunningham T J. 19871217. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma. : Investigational new drugs.

Harvard

Amato D. A., Bruckner H., Guerry D., Ash A., Falkson G., Borden E. C., Creech R. H., Savlov E. D. and Cunningham T. J. (19871217). Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma. : Investigational new drugs.

MLA

Amato D A, Bruckner H, Guerry D, Ash A, Falkson G, Borden E C, Creech R H, Savlov E D and Cunningham T J. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma. : Investigational new drugs. 19871217.